Numerous studies have shown that the inhibition of mutant KRAS activity in PC can effectively control tumor growth resulting in cancer cell death (Ostrem et al., 2013; Buscail et al., 2020; Falcomata et al., 2020; Hong et al., 2020). Here, KRAS is linked to cancer.